Company news
Spago Nanomedical AB news in 2025
Spago Nanomedical AB's news releases, calls and decks from 2025, newest first.
Nomination Committee Appointed for Spago Nanomedical's Annual General Meeting 2026
December 8, 2025
Spago Nanomedical Announces Outcome of Oversubscribed Rights Issue
November 24, 2025
The Subscription Period in Spago Nanomedical's Rights Issue Begins Today
November 7, 2025
Spago Nanomedical Resolves on a Rights Issue of Approximately SEK 25 million to Advance Tumorad
October 29, 2025
Spago Nanomedical Interim Report January-September 2025
October 29, 2025
Visible Tumor Uptake and Recommended Dose Increase in Spago Nanomedicals's Phase I/IIa Study Tumorad-01
October 14, 2025
Spago Nanomedical Interim Report January-June, 2025
August 20, 2025
Spago Nanomedical Continues Patient Recruitment in the Phase I/IIa Study Tumorad-01 as Planned after DMC Recommendation
June 3, 2025
Bulletin from the 2025 Annual General Meeting of Spago Nanomedical AB
May 14, 2025
Spago Nanomedical Interim Report January-March, 2025
May 7, 2025